An Australian Study assessing the effects of Avene Thermal Water Spray in patients with recessive dystrophic epidermolysis bullosa

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611000677909

Enrollment

Registered

2011-07-05

Start date

2011-05-30

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine the efficacy and safety of the Avene Thermal Spring Water (ATSW) in wound healing in patients with recessive dystrophic epidermolysis bullosa. The hypothesis is that the ATSW, instead of bathing, will result in reduced number of infections and improved wound healing.

Interventions

Avene thermal water spray is used to clean all wounds and to clean the skin. This is applied by the patient/carer instead of normal bathing techniques. The frequency will depend on the frequency of bathing and is at the discretion of the patient or carer. Duration of treatment is 6 months.

Study design

Allocation

Non-randomised trial

Primary purpose

Prevention

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Diagnosis of RDEB confirmed by IFM/EM

Exclusion criteria

unable to provide consent pregnant; breastfeeding current participation in another study or trial

Outcome results